Ferronal-Belmed tablets p/o 35 mg No. 10x5

Name

Ferronal-Belmed.

Description

The tablets are film-coated, red-brown in color, biconvex, round in shape.

Main active ingredient

Iron gluconate

Release form

Pills

Dosage

35mg

pharmachologic effect

The drug FERRONAL-BELMED contains an active substance called iron gluconate. Those. FERRONAL-BELMED is an iron preparation. It may be prescribed to you for the treatment and prevention of iron deficiency anemia. Anemia is a condition in which the blood cannot carry enough oxygen to the body due to a decrease in the number of red blood cells. This may cause pale skin, weakness, or shortness of breath. Iron is necessary for the production of hemoglobin (a protein found in red blood cells), which carries oxygen in the body. Iron is also involved in the formation of myoglobin, a pigment that stores oxygen in muscles for use during exercise.

Directions for use and doses

Always take this drug exactly as your doctor has directed you. Contact your doctor if you are unsure about anything. How to take FERRONAL-BELMED:

The tablets must be swallowed whole, without chewing, and washed down with a glass of plain or mineral water;
It is recommended to take the tablets half an hour to an hour before meals;
see the section of this leaflet “Interaction of the drug FERRONAL-BELMED with food and drinks”.

Recommended doses of FERRONAL-BELMED:

adults and adolescents weighing more than 50 kg: 1-2 tablets 2-3 times a day;
children over 6 years old weighing more than 18 kg: 1 tablet 2-3 times a day.

Do not exceed the maximum daily dose (6 mg of iron per 1 kg of body weight) in children! This drug should not be given to children under 6 years of age! How long should you take FERRONAL-BELMED? The duration of treatment depends on the severity of your condition and will be determined by your doctor. Usually, treatment with iron supplements is required for at least 8 weeks to normalize the condition. After normalization of hemoglobin levels to fill the iron depot, treatment is continued for another 6-8 weeks. You should tell your doctor if you do not feel better or if you feel worse. If you take more FERRONAL-BELMED tablets than you need. If you or your child mistakenly took too many tablets of the drug, it is advisable to induce vomiting as soon as possible and contact your doctor immediately. It may be necessary to perform gastric lavage. If you forgot to take the drug FERRONAL-BELMED If you missed taking the drug FERRONAL-BELMED, then, remembering this, you must take the next scheduled dose at the correct time. Do not take a double dose to make up for a missed dose! If you stop taking FERRONAL-BELMED It is important to continue taking FERRONAL-BELMED for the entire period of time prescribed to you by your doctor. Only in this case can one expect to achieve therapeutic success. If you have any additional questions about the use of this drug, consult your doctor.

Use during pregnancy and lactation

If you are pregnant or think you may be pregnant, or if you are breastfeeding, tell your doctor. The use of the drug FERRONAL-BELMED during pregnancy and breastfeeding is permissible with caution and only on the recommendation of the attending physician.

Driving vehicles and machinery

FERRONAL-BELMED does not affect the ability to drive vehicles or operate machinery.

Precautionary measures

Consult your doctor before you start taking FERRONAL-BELMED:

if you are over 60 years old, since with age the risk of developing severe adverse reactions increases;
if you have sugar intolerance. This medicine contains sucrose. If you are intolerant to certain sugars, consult your doctor before taking FERRONAL-BELMED.

Children and adolescents FERRONAL-BELMED should not be used in children under 6 years of age.

Interaction with other drugs

Tell your doctor if you are taking or have recently taken any medications, even those purchased without a prescription. In particular, tell your doctor if you are taking any of the drugs listed below. Co-administration may have a mutual effect on absorption if FERRONAL-BELMED is taken together with:

medicines used to treat bacterial infections (tetracyclines such as doxycycline);
preparations containing aluminum and zinc.

Iron absorption may be reduced if FERRONAL-BELMED is taken together with:

antacids used to treat stomach upset;
preparations containing calcium and magnesium;
trientine (used to treat copper poisoning);
proton pump inhibitors such as omeprazole and lansoprazole, used to treat stomach ulcers;
cholestyramine, used to lower blood cholesterol and control diarrhea.

FERRONAL-BELMED may also interact with:

penicillamine (used to treat Wilson's disease or rheumatoid and juvenile arthritis);
non-steroidal anti-inflammatory drugs;
vitamin E;
carbidopa, levodopa, or entacapone (used to treat Parkinson's disease);
bisphosphonates (used to treat bone disorders such as osteoporosis);
nalidixic acid, neomycin, chloramphenicol, ciprofloxacin, levofloxacin, moxifloxacin, norfloxacin and ofloxacin (used to treat bacterial infections);
methyldopa (used to treat high blood pressure);
mycophenolate (used after organ transplant operations);
thyroxine (used to treat thyroid disease).

The drug should not be taken within the next 2-3 hours before or after taking the above substances. Iron may reduce the absorption of eltrombopag, therefore, an interval of at least 4 hours should be observed between the use of eltrombopag and FERRONAL-BELMED. Interaction of the drug with food and drinks. Simultaneous use of FERRONAL-BELMED with tea, coffee, milk, as well as products containing eggs, may reduce absorption of the drug. Follow the recommendations of your doctor, as well as the information provided in the “Use of the drug” section regarding the rules for taking the drug.

Contraindications

you are allergic to ferrous gluconate or any of the auxiliary components of the drug;
you have a type of anemia that is not due to iron deficiency (non-iron deficiency anemia, for example, sideroblastic anemia, lead anemia, thalassemia);
you have anemia caused by an infection or tumor, with a simultaneous lack of iron;
There is too much iron in your body (hemochromatosis, chronic hemolysis);
You have had repeated blood transfusions;
you are receiving other iron supplements intramuscularly or intravenously;
You are using dimercaprol;
you have gastrointestinal diseases such as inflammatory bowel disease, intestinal strictures and diverticula, acute peptic ulcer;
You abuse alcohol;
You have acute or decompensated liver disease.

If you think that any of the above applies to you, do not take FERRONAL-BELMED. Tell your doctor first and follow his advice.

Compound

The active ingredient of the drug FERRONAL-BELMED is iron (II) 35 mg (corresponding to 300 mg of iron gluconate dihydrate). Other excipients are cellulose powder, talc, stearic acid, highly dispersed silicon dioxide (Aerosil 200), sodium starch glycolate (type A), corn starch. Tablet shell composition: talc, titanium dioxide, shellac, cocoa butter, macrogol 4000, sucrose, calcium carbonate, magnesium stearate, povidone K90, red iron oxide (E172).

Side effect

As with other medications, side effects may occur while taking FERRONAL-BELMED, although they do not occur in all patients. The following adverse reactions have been reported: Common (may occur in no more than 1 in 10 patients): • staining of stools black color, which is caused by iron sulfite formed in the human body. Coloring is absolutely harmless. Uncommon (may occur no more often than 1 in 100 patients): • heartburn, constipation, diarrhea, nausea, vomiting, abdominal pain, allergic reactions (itching, urticaria), skin flushing, pyrexia, dizziness, toothache, pain in chest, sore throat, back pain, gastralgia, irritability. Constipation problems can be resolved by balancing your diet. Reporting Adverse Reactions If you experience any adverse reactions, consult your doctor. This also applies to any side effects that are not listed in this leaflet. You can also report adverse reactions to the information database on adverse reactions (actions) to drugs, including reports of ineffectiveness of drugs (UE “Center for Expertise and Testing in Healthcare M3 RB, website rceth.by”). By reporting adverse reactions, you can help provide more information about the safety of the drug.

Storage conditions

Store in a place protected from moisture and light at a temperature not exceeding 25°C. Keep out of the reach of children. Do not use the drug after the expiration date indicated on the package. The expiration date is the last day of the month. Do not use the drug if you notice that the blister pack in which the tablets are located is damaged. Do not dispose of the drug down the drain or with household waste. Ask your pharmacist how to dispose of medications that you no longer need. These measures will protect the environment.

Buy Ferronal-Belmed tablet/film volume 35 mg in container pack No. 10x5 in the pharmacy

Price for Ferronal-Belmed tablet/film volume 35 mg in container pack No. 10x5

Instructions for use for Ferronal-Belmed tablet/film volume 35 mg in container pack No. 10x5

Ferronal - instructions, composition, dosage, side effects of use

Ferronal

Ferronal _

international and chemical name: iron gluconate;

Main physical and chemical characteristics : wallpaper-convex, film-coated tablets, dark red;

Composition 1 tablet contains iron gluconate – 300 mg;

other ingredients: corn starch, magnesium stearate, titanium dioxide, colloidal silicon dioxide, polyvinyl acetate phthalate, diethyl phthalate, propylene glycol, methocel E5, methocel E15, bright red acid dye 4P.

Medicine release form . Film-coated tablets.

Pharmacological group . Antianemic drugs. Iron supplements. ATS: B03A.

Action of the medicine . Iron, which is part of Ferronal (in the form of gluconate), replenishes iron deficiency in the body, stimulating erythropoiesis. Ferrous gluconate belongs to the blood-forming agents. It promotes rapid restoration of hemoglobin levels in patients with iron deficiency anemia.

Pharmacokinetics. Pharmacokinetics have not been studied.

Indications for use . Prevention and treatment of iron deficiency anemia.

Method of use and dose . It is recommended to take medications after meals to avoid irritation of the food canal.

For preventive purposes, adults are prescribed 1 Ferronal tablet per day, for therapeutic purposes - 3 to 4 tablets per day.

For children 6 - 12 years old, for treatment - 1 - 2 tablets per day.

Maninil description and instructions for use of the drug.

Side effect. When administered orally, iron gluconate is less likely than other iron-containing preparations to cause gastrointestinal disorders such as constipation, diarrhea, and vomiting.

Iron supplements darken stool and may mask undetected bleeding.

Restrictions and contraindications in the use of the drug. Increased individual sensitivity to iron supplements, hemochromatosis, hemosiderosis, aplastic hemolytic anemia.

Interaction with other drugs. Antacids that contain aluminum, magnesium, and calcium salts impair the absorption of iron. Oral medications interfere with the absorption of antibiotics from the tetracycline and penicillin groups. The interval between taking these medications is at least 2 hours.

Exceeding the permissible dose of the drug (overdose). An overdose of Ferronal may cause nausea, pain in the epigastric region, and in severe cases – vomiting, diarrhea, dizziness, acrocyanosis, and low blood pressure. In case of acute poisoning with iron preparations, measures are taken to remove the drug from the alimentary canal. Deferoxamine is used.

Features of use . Ferronal is prescribed to patients with peptic ulcers, enteritis, and ulcerative colitis with extreme caution. Eggs, milk and tea inhibit iron absorption.

Terms and conditions of storage . Keep at a temperature of 25°C + 2°C in a dry place, protected from light and out of reach of children.

Belalgin (Bellalginum) - instructions, composition, dosage, side effects of use

Shelf life: 3 years.

Ferro Sanol 100 mg caps. 50 pieces - Instructions

Dosage form

Capsules, 50 pieces per pack.

Compound

Each capsule contains: iron (II) complex - glycine sulfate 567.7 mg (equivalent to 497.9 mg iron II), (equivalent to 100 mg Fe2 +).

Excipients: ascorbic acid, microcrystalline cellulose, hypromellose, hydroxypropylcellulose, methacrylic acid - ethyl acrylate copolymer, acetyl triethyl citrate, talc, sodium lauryl sulfate, polysorbate 80 and purified water.

Capsule shell: gelatin, titanium dioxide (E171), red iron oxide (E172), black iron oxide (E172) and yellow iron oxide (E172).

pharmachologic effect

Iron preparation in the form of a polymaltose complex of ferric hydroxide. There is a correlation between the degree of iron deficiency and the amount of iron absorbed (the higher the iron deficiency, the better the absorption). Quickly replenishes iron deficiency in the body, stimulates erythropoiesis, and restores hemoglobin levels. During a course of treatment, it promotes gradual regression of clinical (weakness, increased fatigue, dizziness, tachycardia, soreness and dry skin) and laboratory symptoms of anemia.

Pharmacokinetics

In people with iron deficiency, the level of iron absorption from polymaltose hydroxide complex and simple iron salts does not differ. In healthy individuals, iron absorption when taking polymaltose hydroxide complex is very low, which prevents the body from oversaturating with iron.

Suction. Maximum absorption of iron occurs in the duodenum and ileum. The process of active absorption occurs without the formation of highly reactive toxic free radicals.

Metabolism. Iron, in the form of iron (III) oxide, binds to transferrin and is transported to the bone marrow; it is released in red blood cell precursor cells, reduced to ferric oxide (II) and transferred to protoporphyrin for hemoglobin synthesis.

Excretion. Unabsorbed iron is excreted in the feces. Iron excretion occurs during desquamation of the epithelium of the gastrointestinal tract and skin, during breathing, as well as with bile and urine, and amounts to 1 mg of iron per day. In women, iron loss during menstruation also needs to be taken into account.

Indications for the drug Ferro Sanol

- treatment of latent and clinically pronounced iron deficiency (anemia); - prevention of iron deficiency, incl. during pregnancy, during lactation, during childbearing years in women, in children and adolescents, in adults (those following a vegetarian diet and in old age).

Contraindications

The use of Ferro Sanol is contraindicated for:

— excess iron (i.e. with hemochromatosis, hemosiderosis); -impaired iron utilization (for example, lead anemia, sideroachrestic anemia, thalassemia); - other anemias not related to iron deficiency (for example, hemolytic anemia); - hypersensitivity to iron supplements or auxiliary components of the drug.

Pregnancy and lactation

During pregnancy and breastfeeding, Ferro Sanol should be used only after consulting a doctor.

Dosage regimen

Adults and children over 6 years of age take 1 capsule once daily. In cases of severe iron deficiency in adults and adolescents over 15 years of age or over 50 kg body weight (body weight), a dose 2–3 times higher may be prescribed at the beginning of therapy.

Duration of use

The duration of use is determined by the doctor. Depending on the severity of anemia and individual characteristics, it may be necessary to replenish iron reserves in the body for 3 to 6 months.

Side effect

In rare cases, symptoms of gastrointestinal irritation may occur, such as a feeling of heaviness in the stomach, pressure in the epigastric region, nausea, constipation or diarrhea. The dark color of the stool is due to the excretion of unabsorbed iron and has no clinical significance.

Overdose

To date, no cases of intoxication or iron overload have been reported because iron from the active substance of the polymaltose complex of iron (III) hydroxide is not released in the gastrointestinal tract in the form of free ions and is not absorbed by the body through passive diffusion.

Interaction with other drugs

No interaction with other drugs was detected.

Features of application

In case of anemia caused by malignant tumors or infectious diseases, iron is deposited in the reticuloendothelial system, from where it can be mobilized. In such cases

Ferro Sanol is recommended to be used only after the underlying disease has been cured.

Storage conditions

Store at a temperature not exceeding 25°C.

Keep out of the reach of children.

Vacation category

Over the counter.